Immunome, Inc.

Immunome, Inc. is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. The company is advancing an innovative portfolio of therapeutics supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates (ADCs).

Immunome’s pipeline includes varegacestat, an investigational gamma secretase inhibitor for which a New Drug Application (NDA) has been submitted to and accepted by the U.S. Food and Drug Administration; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. The company is also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

The company’s research and development work spans antibody sciences, protein engineering, purification and analytical development, and conjugate chemistry. Immunome operates in-house high-throughput recombinant protein production and characterization capabilities, and works with external contract development and manufacturing organizations (CDMOs) to support its pipeline from preclinical through clinical and commercial stages.

Immunome describes its mission in terms of making a difference in the lives of cancer patients by contributing to the development of best-in-class targeted cancer therapies. The company states that its team works with some of the brightest and most experienced minds in antibody-drug conjugate development.

According to the company, Immunome’s office is charged with the collective excitement and passion of people working together to develop life-changing cancer medicines. The company says its team thrives in an innovative, collaborative environment where employees are empowered to do their best work, and it describes itself as growing quickly.

Immunome offers a comprehensive benefits program for employees and their families, including medical, dental, and vision insurance coverage for employees and their dependents, with 100% company-paid medical premiums for employees; a 401(k) with employer match; employer-paid life insurance, short- and long-term disability insurance, and AD&D; paid time off, company holidays, and a week-long winter break between Christmas and New Year’s; and paid parental leave. The company states that it is an equal opportunity employer, celebrates diversity, and is committed to creating an inclusive environment for all employees. Immunome also participates in E-Verify.

Immunome’s headquarters is located in Bothell, Washington, in the Seattle-area biotechnology corridor, where several of its research and development roles are based.